Who owns Revance Therapeutics?
- CUSIP Number: 761330959
Tip: Access positions for across all investors
Analyze quarterly positions in Revance Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Revance Therapeutics stock
Who bought or sold Revance Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Simplex Trading | 76k | $374k | 32% | Mar 2024 |
|
| Group One Trading | 58k | $287k | -83% | Mar 2024 |
|
| Jane Street | 35k | $171k | 49% | Mar 2024 |
|